Kothari Fermentation & Biochem shareholding pattern

KFBL

38.47

0.31 (-0.80%)
Last updated on 6 Mar, 2026 | 15:11 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Kothari Fermentation & Biochem Shareholding Pattern

  • 2016-17
  • 2021-22
  • 2023-24
  • 2024-25
  • 2025-26
  • 2022-23
  • 2020-21
  • 2019-20
  • 2018-19
Total Promoters
Segment
Percent

Total Promoters

68.87%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

31.13%

Others

0%

Total Promoters
MAR '25
71.66%
JUN '25
70.14%
SEP '25
68.87%
DEC '25
68.87%

Summary

For Year 2025-26, Kothari Fermentation & Biochem reports the following shareholding: Total Promoters at 68.87%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 31.13%. This breakdown provides a quick snapshot of ownership distribution for Kothari Fermentation & Biochem in 2025-26.

Kothari Fermentation & Biochem FAQs

As of 03-2026, the promoter shareholding in Kothari Fermentation & Biochem stands at 68.87% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Kothari Fermentation & Biochem is 0% and 0% respectively.

The retail shareholding of the Kothari Fermentation & Biochem is 31.13%.

Changes in shareholding patterns of Kothari Fermentation & Biochem can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Kothari Fermentation & Biochem are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost